Ligand validation:5Z86

DMU: DECYL-BETA-D-MALTOPYRANOSIDE

DMU is a Ligand Of Interest in 5Z86 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5Z86_DMU_M_101	60%	71%	0.139	0.925	0.45	0.67	-	1	0	0	100%	1
5Z86_DMU_Z_102	31%	70%	0.195	0.864	0.46	0.68	-	1	0	0	100%	1
5Z86_DMU_P_311	22%	67%	0.234	0.849	0.49	0.76	-	-	0	0	100%	1
5Z86_DMU_C_311	16%	50%	0.192	0.761	0.61	1.31	1	8	0	0	100%	1
5Z86_DMU_P_310	10%	58%	0.234	0.732	0.52	1.09	-	2	0	0	100%	1
5Z86_DMU_C_310	8%	58%	0.27	0.74	0.52	1.06	-	3	0	0	100%	1
5Z86_DMU_P_308	3%	68%	0.357	0.712	0.5	0.74	-	-	0	0	100%	1
5Z86_DMU_C_302	2%	70%	0.379	0.675	0.45	0.7	-	1	4	0	100%	1
7COH_DMU_A_526	82%	44%	0.09	0.946	1.05	1.12	2	2	1	0	100%	1
8H8S_DMU_M_101	77%	49%	0.095	0.935	0.98	0.98	2	3	0	0	100%	1
5ZCP_DMU_M_101	77%	40%	0.083	0.921	0.9	1.44	1	6	0	0	100%	1
7CP5_DMU_M_101	77%	52%	0.096	0.934	0.57	1.28	-	4	2	0	100%	1
5ZCO_DMU_M_101	73%	42%	0.108	0.934	0.82	1.43	1	8	0	0	100%	1
6PW0_DMU_A_608	86%	24%	0.098	0.967	1.89	1.24	9	4	1	0	100%	1
3OMI_DMU_B_301	85%	65%	0.096	0.96	0.44	0.9	-	2	0	0	100%	1
7VU0_DMU_A_501	85%	33%	0.079	0.964	1.62	1.06	8	2	0	0	88%	0.8788
2GSM_DMU_A_5001	83%	60%	0.085	0.942	0.5	1.02	-	1	0	0	100%	1
6CI0_DMU_A_602	82%	27%	0.092	0.947	1.91	1.06	10	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.